Assessment of Lymphocyte and Neutrophil Concentration with Many Types of Covid-19 Vaccine in Corona Patients

Hayder Nsiefe Jasim; Issam Jumaa Nasser; Ameerah Mrebee Zarzoor

doi:10.51173/jt.v4i33.765

Authors

Hayder Nsiefe Jasim College of Health & Medical Technology - Baghdad, Middle Technical University, Baghdad, Iraq
Issam Jumaa Nasser College of Health & Medical Technology - Baghdad, Middle Technical University, Baghdad, Iraq
Ameerah Mrebee Zarzoor Middle Technical University, Baghdad, Iraq

DOI:

https://doi.org/10.51173/jt.v4i33.765

Keywords:

Pfizer, AstraZeneca, Sinopharm, Neutrophil, Lymphocyte

Abstract

Coronavirus appeared to be increasing day by day, and the best way to confront this virus was by making effective and safe vaccines, so this study was conducted to compare the types of vaccines that were made against Corona disease in Diyala Governorate. One of the objectives of this study is to know the concentration and number of white cells, specifically lymphocytes and neutrophils, for two groups of people, first unvaccinated patients with corona and second, vaccinated corona patients. The study started from September 2021 to April 2022, and the Present study show there are significant differences (p<0.05) between Neutrophil and Lymphocytes parameters in the studied groups. The WBC count was achieved by full-auto hematology machine manidray technique. Neutrophils scored the highest mean value in vaccinated patients (75.74± 10.39 and 189.41±80.34), and the lowest mean value in healthy (58.32± 9.14 and 6.12±2.14) compared to unvaccinated patient groups. The Lymphocytes scored highest mean value in healthy groups (32.08± 7.64), and lowest mean value in unvaccinated patients’ groups (24.76± 12.34) compared to unvaccinated patients’ groups. The WBCs parameters did not score significant difference within study groups WBCs, Neutrophil, and Lymphocytes parameters showed no significant differences (p>0.05) among vaccine types. Taking into account the normal values and standard units of the results were as follows WBC account (4 – 10.6) x109 /L, the normal value of lymphocyte (20-40) % and neutrophil normal value (40 – 70) %.

Downloads

Download data is not yet available.

References

T. M. Uyeki et al., “Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza,” Clin. Infect. Dis., vol. 68, no. 6, pp. e1–e47, 2019.

B. Zhao et al., “Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids,” Protein Cell, vol. 11, no. 10, pp. 771–775, 2020.

W. Guan et al., “Clinical characteristics of coronavirus disease 2019 in China,” N. Engl. J. Med., vol. 382, no. 18, pp. 1708–1720, 2020.

S. Zhao et al., “Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak,” Int. J. Infect. Dis., vol. 92, pp. 214–217, 2020.

S. A. Lauer et al., “The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application,” Ann. Intern. Med., vol. 172, no. 9, pp. 577–582, 2020.

P. Shi et al., “Impact of temperature on the dynamics of the COVID-19 outbreak in China,” Sci. Total Environ., vol. 728, p. 138890, 2020.

P. Friedlingstein et al., “Global carbon budget 2020,” Earth Syst. Sci. Data, vol. 12, no. 4, pp. 3269–3340, 2020.

L. Ni et al., “Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals,” Immunity, vol. 52, no. 6, pp. 971–977, 2020.

L. Palamenghi, S. Barello, S. Boccia, and G. Graffigna, “Mistrust in biomedical research and vaccine hesitancy: the forefront challenge in the battle against COVID-19 in Italy,” Eur. J. Epidemiol., vol. 35, no. 8, pp. 785–788, 2020.

B. M. Henry, M. H. S. De Oliveira, S. Benoit, M. Plebani, and G. Lippi, “Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis,” Clin. Chem. Lab. Med., vol. 58, no. 7, pp. 1021–1028, 2020.

E. Terpos et al., “Hematological findings and complications of COVID‐19,” Am. J. Hematol., vol. 95, no. 7, pp. 834–847, 2020.

R.-D. Seban, L. Champion, L. H. Schwartz, and L. Dercle, “Spleen glucose metabolism on [18F]-FDG PET/CT: a dynamic double-edged biomarker predicting outcome in cancer patients,” Eur. J. Nucl. Med. Mol. Imaging, vol. 48, no. 8, pp. 2309–2311, 2021.

B. J. Bain and J. M. England, “Normal haematological values: sex difference in neutrophil count.,” Br Med J, vol. 1, no. 5953, pp. 306–309, 1975.

O. Pozdnyakova, N. T. Connell, E. M. Battinelli, J. M. Connors, G. Fell, and A. S. Kim, “Clinical significance of CBC and WBC morphology in the diagnosis and clinical course of COVID-19 infection,” Am. J. Clin. Pathol., vol. 155, no. 3, pp. 364–375, 2021.

Y. Sakiyama, D. B. Graves, H.-W. Chang, T. Shimizu, and G. E. Morfill, “Plasma chemistry model of surface microdischarge in humid air and dynamics of reactive neutral species,” J. Phys. D. Appl. Phys., vol. 45, no. 42, p. 425201, 2012.

E. Akazong, C. Tume, R. Njouom, L. Ayong, V. Fondoh, and J.-R. Kuiate, “Knowledge, attitude and prevalence of hepatitis B virus among healthcare workers: a cross-sectional, hospital-based study in Bamenda Health District, NWR, Cameroon,” BMJ Open, vol. 10, no. 3, p. e031075, 2020.

S. Lu et al., “CDD/SPARCLE: the conserved domain database in 2020,” Nucleic Acids Res., vol. 48, no. D1, pp. D265–D268, 2020.

Á. Geirsdóttir, G. H. Miller, D. J. Larsen, and S. Ólafsdóttir, “Abrupt Holocene climate transitions in the northern North Atlantic region recorded by synchronized lacustrine records in Iceland,” Quat. Sci. Rev., vol. 70, pp. 48–62, 2013.

D. E. Lee, N. Ayoub, and D. K. Agrawal, “Mesenchymal stem cells and cutaneous wound healing: novel methods to increase cell delivery and therapeutic efficacy,” Stem Cell Res. Ther., vol. 7, no. 1, pp. 1–8, 2016.

F. F. MUTLA and H. K. ELAIBI, “The Change Complete Blood Count and Other Inflammatory Markers Before and After Sinopharm Coronavirus Vaccine”. vol. 35, no. 8, pp. 785–788, 2021.

B. A. C. O. N. B. Collaboration, “Frequency ratio measurements at 18-digit accuracy using an optical clock network,” Nature, vol. 591, no. 7851, pp. 564–569, 2021.

D. Terentes-Printzios, N. Ioakeimidis, K. Rokkas, and C. Vlachopoulos, “Interactions between erectile dysfunction, cardiovascular disease and cardiovascular drugs,” Nat. Rev. Cardiol., vol. 19, no. 1, pp. 59–74, 2022.